The Hidden Barrier: Transportation
Clinical trials often require regular visits. But when getting there becomes a hassle, or simply not possible, patients may miss appointments. This not only affects their own care, but also the overall success of the trial. For those with chronic conditions or limited mobility, transportation can be one of the biggest barriers to participation.
Why Taxis Aren’t Always the Answer
Sure, taxis are convenient, but they aren’t always ideal for patients. Here’s why:
- Comfort & Accessibility: Standard taxis often don’t meet the needs of patients with mobility aids or other special requirements. Specialized vehicles offer a safer, more comfortable ride.
- Affordability: Taxi fares can add up quickly, especially with frequent appointments. Providing low-cost or free transportation removes a major financial hurdle.
- Reliability: When transportation is dependable, patients are more likely to stay engaged and stick to their appointment schedules.
- Peace of Mind: Less stress about getting there means patients can focus on what really matters, their health.
Smarter Transportation Options
Many organizations are rethinking how they support patients’ travel needs. Some effective options include:
- Private Sedan Services
Comfortable, direct transportation tailored to individual needs. - Ride-Sharing Programs
Partnering with services like Uber Health or Lyft for Healthcare. - Shuttle Services
Especially helpful for patients staying in nearby hotels. - Travel Assistance
Reimbursements, prepaid cards, or stipends help ease the financial burden.
Putting Patients First
Transportation may seem like a small detail, but it has a big impact. By offering practical, patient-friendly travel solutions, clinical trials become more inclusive, participation rates go up, and outcomes improve. When we put patients first, everyone benefits, from the individuals receiving care to the teams running the research.
En savoir plus
Accès équitable aux essais cliniques : garantir le succès du recrutement
Visitez-nous sur LinkedIn
